000 | 01693 a2200457 4500 | ||
---|---|---|---|
005 | 20250511182052.0 | ||
264 | 0 | _c19920807 | |
008 | 199208s 0 0 eng d | ||
022 | _a0160-2446 | ||
024 | 7 |
_a10.1097/00005344-199219001-00008 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aCournot, A | |
245 | 0 | 0 |
_aHemodynamic effects of carvedilol after acute oral administration in hypertensive and normal subjects. _h[electronic resource] |
260 |
_bJournal of cardiovascular pharmacology _c1992 |
||
300 |
_aS35-9 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdministration, Oral |
650 | 0 | 4 |
_aAdrenergic beta-Antagonists _xpharmacology |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAntihypertensive Agents _xadministration & dosage |
650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
650 | 0 | 4 |
_aBrachial Artery _xdrug effects |
650 | 0 | 4 |
_aCarbazoles _xadministration & dosage |
650 | 0 | 4 | _aCarvedilol |
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHemodynamics _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHypertension _xdrug therapy |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aPropanolamines _xadministration & dosage |
650 | 0 | 4 |
_aRegional Blood Flow _xdrug effects |
650 | 0 | 4 |
_aVascular Resistance _xdrug effects |
650 | 0 | 4 |
_aVasodilation _xdrug effects |
700 | 1 | _aLim, C | |
700 | 1 | _aDuchier, J | |
700 | 1 | _aSafar, M | |
773 | 0 |
_tJournal of cardiovascular pharmacology _gvol. 19 Suppl 1 _gp. S35-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1097/00005344-199219001-00008 _zAvailable from publisher's website |
999 |
_c1384641 _d1384641 |